Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 102.87%5.75B | 30.36%6.01B | 17.05%3.73B | -20.31%6.07B | -50.87%2.83B | -48.49%4.61B | -44.63%3.19B | -17.19%7.62B | -26.41%5.77B | 9.11%8.95B |
Transactional financial assets | 270.31%2.27B | -32.13%2.66B | 53.63%2.16B | -11.43%3.47B | -40.53%613.28M | 112.21%3.92B | 126.03%1.41B | 59.60%3.92B | -29.59%1.03B | -8.36%1.85B |
Notes receivable and accounts receivable | 25.94%286.5M | 34.46%282.47M | 27.51%239.17M | -0.62%216.34M | -3.89%227.49M | -16.00%210.07M | -20.78%187.58M | 4.13%217.7M | 1.52%236.69M | -24.54%250.1M |
-Notes receivable | 26.88%12.94M | 106.25%16.5M | 21.47%19.8M | -72.23%11.1M | -80.53%10.2M | -83.33%8M | -61.07%16.3M | 34.03%39.98M | 5.50%52.38M | 39.54%48M |
-Accounts receivable | 25.90%273.56M | 31.62%265.97M | 28.08%219.37M | 15.49%205.24M | 17.89%217.29M | -0.01%202.07M | -12.13%171.28M | -0.85%177.72M | 0.45%184.31M | -31.96%202.1M |
Other receivables (including interest and dividends) | 404.55%93.97M | 197.41%72.21M | 229.71%80.57M | 330.20%85.6M | -9.39%18.62M | -80.86%24.28M | -9.62%24.44M | -56.32%19.9M | -54.82%20.55M | 260.25%126.87M |
-Dividend receivable | --20.03M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other receivable | 297.01%73.94M | ---- | 229.71%80.57M | ---- | -9.39%18.62M | ---- | -9.62%24.44M | ---- | -54.82%20.55M | ---- |
Contractual assets | 0.00%129.33M | -38.84%129.33M | -38.84%129.33M | -38.84%129.33M | -38.84%129.33M | -36.66%211.45M | -41.58%211.45M | -41.58%211.45M | -27.67%211.45M | --333.84M |
Advance payment | 66.62%149.34M | 90.69%156.8M | 51.41%121.33M | 54.26%120.13M | -14.72%89.63M | -30.38%82.23M | -23.25%80.13M | -41.26%77.88M | -37.98%105.1M | -56.17%118.11M |
Inventories | -16.19%6.93B | -19.71%6.25B | -8.49%7.1B | 17.10%7.14B | 35.05%8.27B | 15.63%7.78B | 11.96%7.76B | 6.11%6.09B | 7.98%6.12B | -7.21%6.73B |
Non-current assets due within one year | --30M | --30M | ---- | ---- | ---- | ---- | ---- | ---- | --104.76M | --103.8M |
Other current assets | -44.04%2.15B | -30.14%2.85B | -16.42%2.65B | -8.40%3.49B | 78.15%3.84B | 306.67%4.08B | 232.13%3.17B | 69.03%3.81B | 32.66%2.15B | -31.25%1B |
Exceptional items of current assets | -76.58%60.84M | -60.59%78.45M | -21.00%139.84M | 12.92%156.29M | 17.15%259.75M | 7.79%199.05M | 0.27%177.02M | -2.40%138.41M | 21.40%221.73M | 118.73%184.67M |
Total current assets | 8.98%17.85B | -13.14%18.52B | -0.31%16.35B | -5.34%21.28B | 1.87%16.38B | 6.34%21.32B | 4.22%16.4B | 3.38%22.49B | -8.24%16.08B | -1.00%20.05B |
Non Current assets | ||||||||||
Other non-current financial assets | ---- | ---- | ---- | ---- | ---- | -5.44%61.59M | -21.42%61.78M | -12.42%72.35M | -17.80%63.65M | -14.37%65.14M |
Long-term equity investment | 21.15%264.51M | 28.74%261.65M | 3.71%225.25M | 13.23%222.31M | 20.04%218.34M | 21.04%203.24M | 37.91%217.2M | -43.36%196.33M | -46.34%181.89M | -47.20%167.91M |
Fixed assets | -1.06%16.89B | ---- | 7.47%17.17B | ---- | 12.59%17.07B | ---- | 22.26%15.98B | ---- | 39.96%15.16B | ---- |
Constru in process | -67.37%283.59M | ---- | -80.50%383.85M | ---- | -67.94%869.14M | ---- | -33.53%1.97B | ---- | -11.81%2.71B | ---- |
Construction materials | -56.49%5.76M | ---- | -50.86%10.29M | ---- | -12.46%13.25M | ---- | 0.32%20.93M | ---- | -36.27%15.13M | ---- |
Productive biological assets | 7.21%299.38M | 9.39%300.14M | 1.38%312.86M | -9.40%305.74M | -17.97%279.26M | -11.60%274.37M | 54.29%308.61M | 64.96%337.48M | 83.18%340.45M | 78.98%310.36M |
Intangible assets | -8.08%1.18B | -8.04%1.19B | -7.13%1.2B | -7.08%1.21B | 4.83%1.28B | 6.40%1.29B | 22.13%1.29B | 22.79%1.3B | 14.70%1.22B | 18.18%1.21B |
Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | 73.79%18.83M | 85.38%18.06M |
Long deferred expense | -16.28%54.04M | -23.50%56.67M | -13.49%59.98M | 3.93%59.59M | 7.83%64.55M | 28.76%74.09M | 37.05%69.34M | 3.73%57.34M | 5.51%59.86M | 17.41%57.54M |
Deferred tax assets | -11.13%135.16M | -0.47%147.67M | -18.77%128.05M | -9.19%144.8M | -13.10%152.08M | -3.85%148.37M | 18.44%157.64M | 40.28%159.45M | 49.52%175.01M | -28.28%154.31M |
Usufruct assets | -6.97%314.56M | -4.07%322.62M | -4.12%328.11M | -4.78%332.01M | -2.56%338.14M | -9.27%336.32M | -8.90%342.22M | -3.90%348.68M | -2.63%347.04M | 3.96%370.68M |
Other non current assets | 39.26%9.44M | -63.88%10.46M | 92.73%49.37M | -2.73%38.33M | -80.72%6.78M | -52.07%28.95M | -66.30%25.62M | -64.95%39.41M | -83.54%35.16M | -81.49%60.4M |
Total non current assets | -4.24%19.44B | -3.95%19.71B | -2.80%19.87B | -1.27%20.11B | -0.18%20.3B | 5.84%20.52B | 12.34%20.44B | 20.48%20.37B | 23.57%20.34B | 28.34%19.39B |
Total assets | 1.66%37.29B | -8.63%38.22B | -1.69%36.22B | -3.41%41.4B | 0.72%36.68B | 6.09%41.83B | 8.57%36.84B | 10.86%42.86B | 7.17%36.41B | 11.53%39.43B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 18.64%7.1B | -14.03%9.69B | 10.08%7.14B | 9.25%10.9B | 90.10%5.98B | 26.87%11.27B | 82.64%6.48B | 56.71%9.98B | 34.62%3.15B | 60.64%8.88B |
Notes payable and accounts payable | -33.58%2.48B | -14.56%2.54B | -11.54%2.76B | -12.66%2.55B | -4.67%3.74B | -6.32%2.97B | 6.54%3.12B | 52.38%2.92B | 82.78%3.92B | 51.75%3.17B |
-Notes payable | --100K | --100K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Accounts payable | -33.58%2.48B | -14.56%2.54B | -11.54%2.76B | -12.66%2.55B | -4.67%3.74B | -6.32%2.97B | 6.54%3.12B | 54.85%2.92B | 85.43%3.92B | 54.28%3.17B |
Contract liabilities | 20.36%2.37B | 8.50%2.15B | -9.17%1.82B | -18.29%1.91B | -36.56%1.97B | -21.36%1.99B | -14.93%2B | 15.85%2.34B | 39.69%3.1B | 38.42%2.53B |
Advance receipts | 78.07%5.13M | 46.51%4.49M | 133.34%5.09M | 697.21%10.87M | 144.30%2.88M | 138.11%3.07M | 118.06%2.18M | 94.94%1.36M | 262.46%1.18M | --1.29M |
Salaries payable | 5.60%857.08M | -12.08%758.85M | -18.37%589.55M | -21.84%465.27M | -21.04%811.63M | 8.13%863.16M | 21.77%722.26M | 35.06%595.27M | 9.03%1.03B | -2.02%798.29M |
Taxs payable | 73.83%691.03M | 1.73%535.29M | 5.19%423.38M | 12.59%532.22M | -16.92%397.52M | 8.79%526.2M | 2.58%402.5M | 4.78%472.71M | 28.39%478.51M | -4.81%483.68M |
Other payable (including interest and dividends) | 2.24%837.92M | -7.74%729.23M | -18.16%732.87M | -13.11%702.2M | -9.16%819.58M | -18.44%790.37M | -14.28%895.52M | 3.59%808.12M | 14.10%902.22M | 16.04%969.11M |
-Dividend payable | -46.39%29.46M | -38.78%11.21M | -10.97%39.34M | 25.86%26.07M | -35.27%54.95M | --18.31M | --44.19M | 64.14%20.72M | 140.43%84.89M | ---- |
-Other payable | 5.73%808.46M | ---- | -18.54%693.53M | ---- | -6.45%764.64M | ---- | -18.51%851.33M | ---- | 8.19%817.33M | ---- |
Non current liabilities due within one year | -76.79%15.35M | -76.89%14.73M | 13.04%14.4M | -81.51%15.16M | -18.84%66.13M | -21.77%63.73M | -84.31%12.74M | 449.14%81.98M | 523.03%81.47M | 407.66%81.46M |
Other current liabilities | 22.67%167.93M | 12.74%146.23M | -9.61%121.2M | -25.78%121.79M | -45.98%136.89M | -26.01%129.71M | -20.05%134.09M | 19.08%164.1M | 65.71%253.4M | 22.92%175.3M |
Total current liabilities | 4.29%14.62B | -15.21%16.66B | -4.48%13.89B | -4.68%17.58B | 3.81%14.02B | 9.19%19.65B | 23.84%14.54B | 39.83%18.44B | 35.36%13.5B | 40.53%18B |
Current liabilities | ||||||||||
Long term loan | -15.74%810.38M | -15.70%810.58M | 6,414.31%811.04M | 6,755.57%811.04M | 7,728.61%961.79M | 7,966.54%961.54M | 1.85%12.45M | -2.38%11.83M | -4.25%12.29M | -9.99%11.92M |
Deferred tax liabilities | -3.39%261.98M | 0.87%301.44M | 6.41%291.46M | 16.69%295.1M | 9.71%271.16M | 17.35%298.84M | 11.12%273.89M | -0.58%252.89M | -7.46%247.17M | 23.34%254.66M |
Long term deferred income | -1.41%69.07M | -70.79%72.14M | -70.19%74.79M | -72.64%70.1M | -73.32%70.06M | -9.56%246.94M | -13.13%250.87M | -10.50%256.22M | -10.07%262.62M | -5.14%273.03M |
Lease liabilities | -4.55%200.83M | 0.74%205.59M | 0.49%206.59M | 1.13%207.35M | 1.86%210.41M | -9.06%204.07M | -9.45%205.6M | -7.60%205.03M | -4.28%206.57M | 7.71%224.39M |
Total non current liabilities | -11.31%1.34B | -18.79%1.39B | 86.30%1.38B | 90.59%1.38B | 107.70%1.51B | 124.00%1.71B | -4.10%742.81M | -13.54%725.97M | -14.60%728.65M | -2.25%764.01M |
Total liabilities | 2.77%15.96B | -15.50%18.05B | -0.07%15.28B | -1.07%18.96B | 9.13%15.53B | 13.86%21.37B | 22.12%15.29B | 36.63%19.17B | 31.42%14.23B | 38.07%18.76B |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%3.46B | 0.00%3.46B | 0.00%3.46B | 0.00%3.46B | 0.00%3.46B | 0.00%3.46B | 0.00%3.46B | 0.00%3.46B | 0.00%3.46B | 0.00%3.46B |
Capital reserve funds | -0.00%8.06B | -0.00%8.06B | -0.00%8.06B | 0.00%8.06B | 0.00%8.06B | -0.07%8.06B | -0.07%8.06B | -0.12%8.06B | -0.12%8.06B | -0.05%8.07B |
Surplus reserve funds | 0.00%1.83B | 0.00%1.83B | 0.00%1.83B | 0.00%1.83B | 0.00%1.83B | 0.00%1.83B | 0.00%1.83B | 0.00%1.83B | 0.00%1.83B | 0.00%1.83B |
Retained profit | 3.68%7.6B | -3.12%6.43B | -6.91%7.21B | -12.69%8.61B | -12.35%7.33B | -2.73%6.63B | 2.36%7.74B | -8.64%9.86B | -10.29%8.37B | -13.87%6.82B |
Other composite income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --96.41K |
Ordinary risk reserve funds | 4.15%144.87M | 20.29%139.1M | 20.29%139.1M | 20.29%139.1M | 20.29%139.1M | 4.76%115.63M | 4.76%115.63M | 4.76%115.63M | 4.76%115.63M | 0.91%110.38M |
Specific reserves | 3.87%10.05M | 5.34%9.86M | 5.15%10.21M | 6.52%10.03M | 4.89%9.68M | --9.36M | 10,804.10%9.71M | --9.41M | --9.23M | ---- |
Shareholders equity without minority interests | 1.32%21.12B | -0.91%19.93B | -2.41%20.71B | -5.25%22.11B | -4.62%20.84B | -0.87%20.12B | 0.89%21.23B | -3.82%23.34B | -4.19%21.85B | -5.15%20.29B |
Minority interests | -31.84%206.88M | -33.24%234.31M | -30.97%228.14M | -8.23%318.42M | -7.94%303.5M | -5.69%350.94M | -12.36%330.52M | -3.97%346.98M | -3.32%329.66M | 1.46%372.11M |
Total shareholder equity | 0.85%21.33B | -1.47%20.17B | -2.85%20.94B | -5.30%22.43B | -4.67%21.15B | -0.96%20.47B | 0.66%21.56B | -3.82%23.69B | -4.18%22.18B | -5.04%20.67B |
Total liabilityies and equity | 1.66%37.29B | -8.63%38.22B | -1.69%36.22B | -3.41%41.4B | 0.72%36.68B | 6.09%41.83B | 8.57%36.84B | 10.86%42.86B | 7.17%36.41B | 11.53%39.43B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.